Breast Cancer Research

Breast Cancer Research

Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.

Clinical Trials

A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens including Rare Pediatric Tumors.
Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)
Umbrella Long-term Follow-up Protocol
PALLAS: PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination with Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-024
Children's Lives Include Moments of Bravery (CLIMB)
Role of TRP Channel Isoforms in Breast Cancer
Patterns of Patient Care in Appalachia
An Observational Trial of the Phase I and II Metabolism Profile of Exemestane in Breast Cancer Patients
Clinicopathologic Study of Breast Cancer
Sirtuin 3 (SIRT3): A Novel Predictive Biomarker for Tamoxifen Resistance
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
Protocol for a Research Database for Hematopoietic Cell Transplantation, other Cellular Therapies and Marrow Toxic Injuries.

Disease Team Members

First Name Last Name Title Role
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Alison Chetlen, DO Alison Chetlen DO View Profile
Leah Cream, MD Leah Cream MD View Profile
Daleela Dodge, MD Daleela Dodge MD View Profile
Harold Harvey, MD Harold Harvey MD View Profile
Claudia Kasales, MD Claudia Kasales MD View Profile
Rena Kass, MD Rena Kass MD View Profile
Julie Mack, MD Julie Mack MD View Profile
Rogerio Neves, MD, PhD Rogerio Neves MD, PhD View Profile
Melody Paulishak, DO Melody Paulishak DO View Profile
John Potochny John Potochny View Profile
Jennifer Rosenberg, MD Jennifer Rosenberg MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Susann Schetter, DO Susann Schetter DO View Profile
Rebecca Sivarajah, MD Rebecca Sivarajah MD View Profile
Cristina Truica, MD Cristina Truica MD View Profile
Meredith Watts, MD Meredith Watts MD View Profile
Kristine Widders, MD Kristine Widders MD View Profile
Nicholas Zaorsky, MD Nicholas Zaorsky MD View Profile
Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens including Rare Pediatric Tumors.
Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)
Umbrella Long-term Follow-up Protocol
PALLAS: PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination with Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-024
Children's Lives Include Moments of Bravery (CLIMB)
Role of TRP Channel Isoforms in Breast Cancer
Patterns of Patient Care in Appalachia
An Observational Trial of the Phase I and II Metabolism Profile of Exemestane in Breast Cancer Patients
Clinicopathologic Study of Breast Cancer
Sirtuin 3 (SIRT3): A Novel Predictive Biomarker for Tamoxifen Resistance
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
Protocol for a Research Database for Hematopoietic Cell Transplantation, other Cellular Therapies and Marrow Toxic Injuries.
First Name Last Name Title Role
Ayodele Ayoola, MD Ayodele Ayoola MD View Profile
Alison Chetlen, DO Alison Chetlen DO View Profile
Leah Cream, MD Leah Cream MD View Profile
Daleela Dodge, MD Daleela Dodge MD View Profile
Harold Harvey, MD Harold Harvey MD View Profile
Claudia Kasales, MD Claudia Kasales MD View Profile
Rena Kass, MD Rena Kass MD View Profile
Julie Mack, MD Julie Mack MD View Profile
Rogerio Neves, MD, PhD Rogerio Neves MD, PhD View Profile
Melody Paulishak, DO Melody Paulishak DO View Profile
John Potochny John Potochny View Profile
Jennifer Rosenberg, MD Jennifer Rosenberg MD View Profile
Marc Rovito, MD Marc Rovito MD View Profile
Susann Schetter, DO Susann Schetter DO View Profile
Rebecca Sivarajah, MD Rebecca Sivarajah MD View Profile
Cristina Truica, MD Cristina Truica MD View Profile
Meredith Watts, MD Meredith Watts MD View Profile
Kristine Widders, MD Kristine Widders MD View Profile
Nicholas Zaorsky, MD Nicholas Zaorsky MD View Profile

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)